ANDA 74099, held by Novitium Pharma. Atenolol.
As of Nov 15, 2026, ANDA 74099 (Atenolol), held by Novitium Pharma, was first approved by FDA on Apr 28, 1992, with 20 approved supplements and 0 published complete response letters.
| Date | Submission | Status | Documents |
|---|---|---|---|
| Apr 28, 1992 | Original application | Approved | None posted |
| Product | Active ingredient | Marketing |
|---|---|---|
| Atenolol25MG · tablet;oral | Atenolol | Discontinued |
| Jul 29, 2025 | Supplement 31Labeling · Standard review | Approved | None posted |
| Jul 29, 2025 | Supplement 30Labeling · Standard review | Approved | None posted |
| Sep 14, 2005 | Supplement 21Labeling | Approved | None posted |
| May 21, 2001 | Supplement 19Manufacturing | Approved | None posted |
| Jun 5, 2000 | Supplement 16Labeling | Approved | None posted |
| May 24, 1999 | Supplement 15Manufacturing | Approved | None posted |
| Apr 5, 1999 | Supplement 14Manufacturing | Approved | None posted |
| Mar 12, 1999 | Supplement 13Manufacturing | Approved | None posted |
| Jul 30, 1997 | Supplement 12Manufacturing | Approved | None posted |
| Jul 30, 1997 | Supplement 11Manufacturing | Approved | None posted |
| Feb 18, 1997 | Supplement 10Labeling | Approved | None posted |
| Jun 10, 1996 | Supplement 9Manufacturing | Approved | None posted |
| May 15, 1996 | Supplement 8Manufacturing | Approved | None posted |
| May 15, 1996 | Supplement 7Manufacturing | Approved | None posted |
| Oct 4, 1994 | Supplement 5Manufacturing | Approved | None posted |
| Sep 8, 1994 | Supplement 6Labeling | Approved | None posted |
| Jan 14, 1994 | Supplement 3Manufacturing | Approved | None posted |
| Dec 13, 1993 | Supplement 4Labeling | Approved | None posted |
| Feb 4, 1993 | Supplement 2Labeling | Approved | None posted |
| Sep 25, 1992 | Supplement 1Labeling | Approved | None posted |
| Apr 28, 1992 | Original application | Approved | None posted |
Approvals, supplements, products and documents come from FDA's Drugs@FDA data files, refreshed daily; Drugs@FDA lists approved applications only. Complete response letters are FDA's published letters. Drugs@FDA and FDA complete response letters